Pharmacy Costs: Can I Make a Difference?

Similar documents
Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica

Daiichi Sankyo, Inc. (DSI)

Generics. Lead with. P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

Cost Effectiveness Recommendations For Kentucky Retirement Systems MTM Plan 2011

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

PDF created with pdffactory trial version

Hypertension JNC 8 (2014)

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Medications for Treating Stroke

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

Simvastatin 40 mg equivalent

Physician/Clinic Collaborative Practice Agreement

JPMorgan Investor Meeting

Strategies for Managing Hypertension

RxBlue 2010 ST Criteria

Generics. Lead with. Prescription Step Therapy Program

Using the New Hypertension Guidelines

Adult Blood Pressure Clinician Guide June 2018

Combination Therapy for Hypertension

The Weekly Mortar & Pestle

Renal Disease through the Ages: From Childbearing years to Old Age. Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician.

Pravastatin conversion to atorvastatin

Management of High Blood Pressure in Adults

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

STATIN UTILIZATION MANAGEMENT CRITERIA

9/13/2017. Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH. Introduction Background Management

Steps Against Recurrent Stroke (STARS)

Information for Vermont Prescribers of Prescription Drugs

Blood Pressure Treatment in 2018

Have you been paying for your prescription drugs? Stop!

Information for Vermont Prescribers of Prescription Drugs

Hypertension Pharmacotherapy: A Practical Approach

Steps Against Recurrent Stroke (STARS)

Diseases & Conditions

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

Clinical Recommendations: Patients with Periodontitis

Hypertension (JNC-8)

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Anthem Prescription Management s Clinical Connections Program

AGGRENOX. Products Affected. Details. GRP B2 Last Updated: 09/01/2018. Aggrenox

Understanding Your Patient Care Opportunity Report (PCOR)

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care

Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

See Important Reminder at the end of this policy for important regulatory and legal information.

DEPARTMENT OF GENERAL MEDICINE WELCOMES

Prescription Drugs. Medicare & Medicaid Briefings National Health Policy Forum February 22, Jim Hahn Congressional Research Service

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

ADVANCES IN MANAGEMENT OF HYPERTENSION

Doctor discussion guide:

Long-Term Care Updates

C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario

Your cholesterol levels. Questions or concerns

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Doctor discussion guide:

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

Steps Against Recurrent Stroke (STARS)

CONCORD INTERNAL MEDICINE HYPERTENSION PROTOCOL

Six strategies to identify and assist patients burdened by out-of-pocket prescription costs

Pharmaceutical Help to Control Cholesterol

Hypertension Management Controversies in the Elderly Patient

Safe, effective, affordable drug choices: online tool for payers and patients.

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

AGGRENOX. Products Affected. Details. First Health Part D Value Plus (PDP) Last Updated: 10/01/2017. Aggrenox

Layered Approaches to Studying Drug Responses

CHOLESTEROL REDUCING MEDICATIONS. Five Main Categories. 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor

ADVANCES IN MANAGEMENT OF HYPERTENSION

Copyright 2013 by Janet Brill All rights reserved. Published in the United States by Three Rivers Press, an imprint of the Crown Publishing Group, a

Pharmacy benefit guide

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

Get Healthy Stay Healthy

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Information in these slides is used with permission from St. Mary s Cardiac Rehab

Cholesterol. Medicines To Help You

Don t let the pressure get to you:

Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

STEP THERAPY ALGORITHMS PUP Select Formulary

Conversion of crestor to lipitor

Essays on the Economics of Drug Prescribing and Utilization. Mariana Patricia Carrera

Achieving a Culture of Employee Health and Wellness

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

TAKING LUVOX AND WELLBUTRIN TOGETHER

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

Realized Savings from Generic Drugs in Upstate New York

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

TRENDS IN MANUFACTURER PRICES OF BRAND-NAME PRESCRIPTION DRUGS USED BY OLDER AMERICANS SECOND QUARTER 2006 UPDATE

HealthPartners Care Coordination Clinical Care Planning and Resource Guide HYPERTENSION

Transcription:

Pharmacy Costs: Can I Make a Difference?

Pharmaceutical Market Dynamics What is driving Rx cost up? No New Blockbusters Patent Expirations OTC Market Dynamics Availability Pharmaceutical Companies Unfortunately, not all pharma company actions deliver value to the Health Care System. Increase utilization Drive preference Creative packaging New indications Price inflation Specialty drugs Frequent price increases New indications Patent extensions Slight modifications to: Dosage Delivery mechanism Dosage frequency Combination drugs Physicians Do not know Rx costs 80,000 Pharma Reps Sampling of brand drugs Employees Don t always know lower cost options Consuming $5 billion in pharma advertising Requests influence physician prescriptions Newer is better perception Employer Rx Cost Who is protecting your Rx investment?

2009 Generics The Calm Before the Storm $93.1 billion in Brand Drugs Off-Patent from 2008-2015 2008: Risperdal, Lamictal, Fosamax, Imitrex 2009: Adderall, Prevacid, Topamax, Valtrex $20.9 2010: Effexor XR, Flomax, Cozaar, Hyzaar $11.6 $18.5 $15.0 2011: Lipitor, Actos, Protonix, Zyprexa, Levaquin, Aricept 2012: Plavix, Singulair, Seroquel, Lexapro, Diovan, Avandia $9.3 $6.5 $7.3 $4.0 2013: Cymbalta, Celebrex, Aciphex 2014: Nexium, Vytorin, Zetia, Lyrica, Nasonex 2015: Abilify 2008 2009 2010 2011 2012 2013 2014 2015

Value Value = Outcome Cost

What is the # 1 diagnosis at ThedaCare?

Treatment of Hypertension Algorithm Source: JNC 7 (http://www.nhlbi.nih.gov)

Compelling Indications for Individual Drug Classes Compelling Indication Initial Therapy Options Heart Failure Postmyocardial infarction High CVD risk Diabetes Chronic kidney disease Recurrent stroke prevention THIAZ, BB, ACEI, ARB, ALDO ANT BB, ACEI, ALDO ANT THIAZ, BB, ACEI, CCB THIAZ, BB, ACEI, ARB, CCB ACEI, ARB THAIZ, ACEI THAIZ = thiazide diuretic; ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; BB = beta blocker; CCB = calcium channel blocker; ALDO ANT = aldosterone antagonist Source: JNC 7 (http://www.nhlbi.nih.gov)

Lifestyle Modification Recommendations Modification Recommendation Average SBP Reduction Range* Weight reduction DASH eating plan Maintain normal body weight (body mass index 18.5 24.9 kg/m 2 ) Adapt a diet rich in fruits, vegetables, and lowfat dairy products with reduced content of saturated fat 5-20 mm Hg/10 kg 8-14 mm Hg Dietary sodium reduction Aerobic physical activity Reduce dietary sodium intake to <100 mmol (2.4 g sodium or 6 g sodium chloride) Regular aerobic physical activity (eg, brisk walking) at least 30 minutes per day, most days of the week 2-8 mm Hg 4-9 mm Hg Moderation of alcohol consumption Men: limit to <2 drinks t per day. Women and lighter-weight persons: limit to <1 drink t per day 2-4 mm Hg * Effects are dose and time dependent t 1 drink ½ oz or 15 ml ethanol (eg, 12 oz beer, 5 oz wine, 1.5 oz 80-proof whiskey) Source: JNC 7 (http://www.nhlbi.nih.gov)

Class: Angiotensin receptor blockers (ARBs) Diovan/Diovan HCT Opportunity Pharma Strategy Price inflation The prices for Diovan/Diovan HCT are expected to increase significantly after 1/1/09 Indication: Hypertension and heart failure Avg. ARB Cost 1 80 70 60 50 40 30 20 10 0 Diovan Diovan will cost 86% more than other Tier 2 ARBs and 15% more than other Tier 3 ARBs. Benefit Patients: Mitigate the expected increased costs for these medications through incentives for higher value, lower cost choices Mitigates increased cost of Diovan and encourages lower cost equivalents

Half Tablet Program Can all pills be split? Is pill splitting for everyone? NO! Once a day dose Flat priced Same clinical outcomes Voluntary tell doctor

Top 3 opportunities for ½ tab program Blood Pressure Meds: ARBs Cholesterol Lowering: Lipitor/Crestor Antidepressants: Lexapro

Caduet Class: Lipid/Cholesterol Lowering Indication: Hypertension, High Cholesterol Opportunity Pharma Strategy Patent extension Combination of atorvastatin (Lipitor) and amlodipine (generic Norvasc). Priced at a premium to individual components. Clinical Assessment Caduet is therapeutically equivalent to atorvastatin and amlodipine taken separately. Lipitor $$ + Generic = Caduet Norvasc $$$$ $ Benefit Patients: Will not pay a high cost for Caduet when individual medications are available at a lower net cost. Patients: Same treatment results by taking individual components; can pay an even lower copayment by switching to another statin. Combination drug with no unique value

Class: Beta Blocker Indication: High Blood Pressure/Heart Failure Coreg CR Opportunity Pharma Strategy Patent extension Coreg CR is priced significantly more than generic Coreg. Clinical Assessment Coreg CR contains the same active ingredient as generic Coreg, but is taken once a day as opposed to twice a day. Generic Coreg $ = Taken twice daily Coreg CR $$$$ Taken once daily Benefit Patients: Will not pay a cost premium for a medication available at a lower cost Patients: Generic Coreg provides the same active ingredient at an affordable cost Me too drug with no added clinical value

Moderate LDL Reduction Lescol XL Pravachol (pravastatin) Mevacor (lovastatin) 25%-34% LDL reduction

Potent LDL Reduction Zocor (simvastatin) Lipitor Crestor 26%-63% LDL reduction

Clinical + Financial Decision $120/$30 $20/$10 copay copay Lipitor LDL reduction simvastatin 10 mg 39% 20 mg 20 mg 43% 40 mg 40 mg 50% 80 mg 80 mg 60%

Zetia 10 mg = 18 % $90 Cheerios = 5 % Oatmeal = 10 %

Vytorin Zetia 10 mg = 18% Zetia 5 mg = 16% #30 Vytorin 10/20 = 45% $90 #15 Vytorin 10/40 = 55% $45

Pharmacy Example (100 Prescriptions with 10 refills) Prescriber A simvastatin 40 mg 30 Rx @ =$0 10 refills =$0 OTC Prilosec 20 mg 30 Rx @ =$0 10 refills =$0 fluoxetine 20 mg 40 Rx @ =$0 10 refills =$0 Total $0 Prescriber B Lipitor 20 mg 30 Rx @ $100 =$3,000 10 refills =$30,000 Nexium 40 mg 30 Rx @ $100 =$3,000 10 refills =$30,000 Cymbalta 60 mg 40 Rx @ $100 =$4,000 10 refills =$40,000 Total $100,000

Questions/Comments?